TAP Using Dexmedetomidine and Ropivacaine for Cesarean Section Analgesia
NCT ID: NCT05700045
Last Updated: 2023-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2023-05-31
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section
NCT02741219
Dexmedetomine vs Dexamethasone in TAB Block for Abdominal Surgries
NCT05323565
Dexamethasone Versus Dexmedetomidine
NCT03064633
Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block
NCT03778671
Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia
NCT03096730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dexmedetomidine + ropivacaine
each side dexmedetomidine 0.5ug/kg+0.25% ropivacaine 20ml TAP block
Dexmedetomidine
each side dexmedetomidine 0.5ug/kg TAP block
ropivacaine
each side 0.25% ropivacaine 20ml TAP block
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
each side dexmedetomidine 0.5ug/kg TAP block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2\) Plan cesarean section
3\) Receiving patient controlled intravenous analgesia
4\) Age\>18 years
5\) ASA（American Society of Anesthesiologists) grade I-III
6\) Voluntary participation and informed consent
Exclusion Criteria
2\) Combined with other opioids during operation
3\) High risk pregnancy (multiple pregnancy, in vitro pregnancy, etc.) or pregnancy related complications (hypertension, preeclampsia, chorioamnionitis, etc.)
4\) Times of previous cesarean section ≥ 3
5\) BMI ≥ 50kg/m2 is not suitable for TAP block
6\) Allergies or contraindications to the drugs involved in the study
7\) Combined with operations other than tubal ligation and ovariectomy
8\) Severe renal function impairment (SCR\>176 µ mol/L and/or blood urea nitrogen\>17.9 mmol/L), severe liver function impairment (ALT and/or aspartate aminotransferase exceed 3 times the upper limit of normal value)
9\) Increased risk of coagulation dysfunction or bleeding (PLT\<80 × 109/L or international normalized ratio\> 1.5)
10\) History of chronic pain or opiate abuse
11\) Other clinical trials in the last three months
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Fourth military medical university, Xijing Hospital
Xi'an, Shannxi, China
Huang Nie
Xi'an, , China
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY-20222263-F-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.